ABOUT
HealthTech Arkansas helps to drive innovation for the ten largest hospitals and health systems in Arkansas, which is accomplished through accelerator programs and internal innovation programming.
Our internal innovation programming is focused on helping our state’s healthcare provider organizations to harvest, organize and develop ideas for new innovations from their own clinicians and administrators. We do that through a variety of specific programs focused on solving real problems and challenges (clinical and administrative in nature) through the development and commercialization of intellectual property to be owned by the provider organization.
HeartX – the annual accelerator currently focused on cardiovascular technologies - guarantees at least two hospital pilot projects or clinical trials for each early-stage company admitted to the program. In addition to the guaranteed pilots, participating companies receive upfront investment from the HealthTech Arkansas Fund.
Our accelerator targets three areas of healthcare innovation: digital health (software), medical devices and diagnostic platforms. Our program is for providers and by providers, so we seek technologies that can improve our providers’ operations by improving quality of care, enhancing efficiencies, reducing costs, etc. In fact, our providers choose the companies invited to participate in the program each year.
Our accelerator is virtual, so there’s no requirement to be in Arkansas other than when you’ll be here to work with your provider partners on your pilot projects or clinical trials. In addition to the guaranteed pilots, participating companies receive upfront investment capital through a SAFE or convertible note.
Applications are now closed for the HeartX Accelerator.
BioAR Trial Accelerator is a new accelerator established to help biotherapeutics companies in late pre-clinical to early-clinical stages of development bring groundbreaking therapies to market faster while increasing Arkansans’ access to cutting-edge clinical care and innovative medicine. The program will begin in April 2023.
SymBiosis and HealthTech Arkansas are partnering to build and execute this accelerator program for biotherapeutics companies ready to conduct a clinical trial within 12 months of entry or for companies moving to the next phase of a clinical trial.
Applications are now closed for the BioAR Trial Accelerator.
PROVIDER PARTNERS
PROGRAM PARTNERS
INTERNATIONAL COOPERATION
OUR TEAM
Jeff Stinson
Director
Amber Neil
Clinical Innovation Manager
Priya Bargoti
Clinical Trials Manager
Haley McCarver
Program Manager
Emily Reeves Dean
Recruiting/Marketing
Dr. Jason Beck
Entrepreneur-in-Residence
Dr. Jay Gandy
Entrepreneur-in-Residence
Dr. Amy Hester
Clinician-in-Residence
CLINICAL ADVISORY BOARD
STrategic Advisory board
